Rosemont Pharmaceuticals are pleased to announce a strategic partnership deal with Exeltis Pharma (Mexico)
In a recent visit to Mexico City, our Head of International Sales, Mark Vallance, and International Sales Manager, Rupert Sargeant, met with our local Partner, Exeltis Healthcare to celebrate the launch of a new product into the LatAm Region
Mark commented, “This is Rosemont’s first product launch in Mexico and would not have been possible without the hard work and dedication from colleagues across both companies. We are really excited about our growing collaboration with Exeltis as we collectively look to bring new liquid products to patients across the world. We also hope that this will be the first of many for the Mexican market!”.
ROS000066-003 January 2024
Rosemont Pharmaceuticals are pleased to announce a strategic partnership deal with Exeltis Pharma (Mexico)
In a recent visit to Mexico City, our Head of International Sales, Mark Vallance, and International Sales Manager, Rupert Sargeant, met with our local Partner, Exeltis Healthcare to celebrate the launch of a new product into the LatAm Region
Mark commented, “This is Rosemont’s first product launch in Mexico and would not have been possible without the hard work and dedication from colleagues across both companies. We are really excited about our growing collaboration with Exeltis as we collectively look to bring new liquid products to patients across the world. We also hope that this will be the first of many for the Mexican market!”.
ROS000066-003 January 2024
Rosemont Pharmaceuticals are pleased to announce a strategic partnership deal with Exeltis Pharma (Mexico)
In a recent visit to Mexico City, our Head of International Sales, Mark Vallance, and International Sales Manager, Rupert Sargeant, met with our local Partner, Exeltis Healthcare to celebrate the launch of a new product into the LatAm Region
Mark commented, “This is Rosemont’s first product launch in Mexico and would not have been possible without the hard work and dedication from colleagues across both companies. We are really excited about our growing collaboration with Exeltis as we collectively look to bring new liquid products to patients across the world. We also hope that this will be the first of many for the Mexican market!”.
ROS000066-003 January 2024